FI930873A - Tetrahydrotiofenderivat - Google Patents

Tetrahydrotiofenderivat Download PDF

Info

Publication number
FI930873A
FI930873A FI930873A FI930873A FI930873A FI 930873 A FI930873 A FI 930873A FI 930873 A FI930873 A FI 930873A FI 930873 A FI930873 A FI 930873A FI 930873 A FI930873 A FI 930873A
Authority
FI
Finland
Prior art keywords
chem
remainder
hydrogen
pharmaceutically acceptable
acceptable salts
Prior art date
Application number
FI930873A
Other languages
English (en)
Finnish (fi)
Other versions
FI930873A0 (fi
Inventor
Shiro Mita
Yoichi Kawashima
Nobuharu Kato
Hiroshi Suhara
Koji Yoneda
Masataka Morishita
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of FI930873A0 publication Critical patent/FI930873A0/fi
Publication of FI930873A publication Critical patent/FI930873A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/08—Bridged systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Organic Insulating Materials (AREA)
  • Control Of Electric Motors In General (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI930873A 1992-02-28 1993-02-26 Tetrahydrotiofenderivat FI930873A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7924992 1992-02-28

Publications (2)

Publication Number Publication Date
FI930873A0 FI930873A0 (fi) 1993-02-26
FI930873A true FI930873A (fi) 1993-08-29

Family

ID=13684588

Family Applications (1)

Application Number Title Priority Date Filing Date
FI930873A FI930873A (fi) 1992-02-28 1993-02-26 Tetrahydrotiofenderivat

Country Status (12)

Country Link
US (1) US5292767A (fr)
EP (1) EP0558287B1 (fr)
JP (1) JP2818919B2 (fr)
KR (1) KR930017877A (fr)
CN (1) CN1035876C (fr)
AT (1) ATE145902T1 (fr)
AU (1) AU648217B2 (fr)
CA (1) CA2090548A1 (fr)
DE (1) DE69306278T2 (fr)
FI (1) FI930873A (fr)
NO (1) NO930679L (fr)
TW (1) TW222629B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1154092A (en) * 1991-01-10 1992-08-17 Santen Pharmaceutical Co. Ltd. Cyclic compound
US5776859A (en) * 1995-11-15 1998-07-07 Nickel; Alfred A. Sodium channel active novel compounds and related processes and bioassay techniques
CN102772783A (zh) * 2007-01-25 2012-11-14 中国生化制药工业协会 血清胸腺因子在制备抗肿瘤药物、肿瘤物理及化学治疗药物的保护药物方面的用途
CN106831513A (zh) * 2017-01-06 2017-06-13 绍兴市上虞区耕创化工技术服务部 硫代乙酸钾的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1154092A (en) * 1991-01-10 1992-08-17 Santen Pharmaceutical Co. Ltd. Cyclic compound

Also Published As

Publication number Publication date
DE69306278D1 (de) 1997-01-16
JPH05301867A (ja) 1993-11-16
CN1035876C (zh) 1997-09-17
JP2818919B2 (ja) 1998-10-30
DE69306278T2 (de) 1997-04-17
KR930017877A (ko) 1993-09-20
EP0558287A1 (fr) 1993-09-01
TW222629B (fr) 1994-04-21
CA2090548A1 (fr) 1993-08-29
ATE145902T1 (de) 1996-12-15
AU648217B2 (en) 1994-04-14
US5292767A (en) 1994-03-08
NO930679D0 (no) 1993-02-25
EP0558287B1 (fr) 1996-12-04
NO930679L (no) 1993-08-30
AU3386093A (en) 1993-09-02
FI930873A0 (fi) 1993-02-26
CN1079739A (zh) 1993-12-22

Similar Documents

Publication Publication Date Title
LU91519I2 (fr) "Doripenem et ses dérivés pharmaceutiquement acceptables - DORIBAXr"
AU579398B2 (en) (Fused) Benz (Thio) Amides
ATE172201T1 (de) Morphinan-derivate und medizinische verwendung
EP0291917A3 (en) Novel oxetanocins
SE8802402D0 (sv) Novel esters
NO930679D0 (no) Tetrahydrotiofenderivater
ATE86866T1 (de) Antikrebs-zusammensetzung.
ES2173182T3 (es) Derivado de 4,6-dl-butil-2,3-dihidrobenzotiofenos como antioxidantes de ldl.
ATE152714T1 (de) Thiazin- oder thiomorpholinderivate
ATE161820T1 (de) Carboxylatderivate mit einer die phospholipase a2 hemmenden aktivität
DK0420224T3 (da) Anthihepatopatisk middel
ATE111456T1 (de) N-alkylthiazolidinderivate.
ES2149180T3 (es) Derivado de pirazolotiazolopirimidina.
ATE178323T1 (de) 3-oxo-1,4-benzothiazinderivate
LU88449I2 (fr) Fleroxacine et ses dérivés pharmaceutiquement acceptables.

Legal Events

Date Code Title Description
FD Application lapsed